BioSpace Collaborative

Academic/Biomedical Research
News & Jobs
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

PROFILES
Company Profiles

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Research Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

 News | News By Subject | News by Disease News By Date | Search News
Get Our Industry eNewsletter FREE email:    
Clinical - Drug Product News (World)
Stolen Roche (RHHBY) Cancer Drug Found On Market 4/17/2014  More...
Ferring Pharmaceuticals Release: UK National Institute for Clinical Excellence (NICE) Guidance Recommends FIRMAGON® (Degarelix) For The Treatment Of Advanced Hormone-Dependent Prostate Cancer Only In People With Spinal Metastases Who Present With Signs Or Symptoms Of Impending Spinal Cord Compression (ISCC) 4/15/2014  More...
Teva Pharmaceutical Industries Limited (TEVA) Announces Launch Of Generic Lunesta® Tablets In The United States 4/15/2014  More...
Sun Pharmaceutical Industries Ltd (SUNPHARMA.NS) Plans To Gradually Phase-Out Of Ranbaxy Laboratories (RANBAXY.BO)-Branded Drugs In U.S. 4/9/2014  More...
Swedish Orphan Biovitrum Becomes Market Authorisation Holder For Xiapex In Europe 4/7/2014  More...
Aerocrine Release: National Institute for Clinical Excellence (NICE) Recommends The Use Of Exhaled Nitric Oxide (Feno) Testing To Help Diagnose And Manage Asthma 4/2/2014  More...
Swedish Orphan Biovitrum Assumes Direct Responsibility For Orfadin® (Nitisinone) In U.S. And Canada And Introduces Orfadin4U™ 4/1/2014  More...
Sanofi (France) (SAN.PA) Release: National Institute for Clinical Excellence (NICE) Rejects Life-Extending Bowel Cancer Drug Two Weeks After Scottish Approval 3/25/2014  More...
UK Cancer Drugs Fund Adds Roche (RHHBY), Celgene Corporation (CELG) And Exelixis, Inc. (EXEL) Drugs 3/24/2014  More...
UK Cost Agency Says "No" To Bayer AG (BAYN.DE) Prostate Cancer Drug Xofigo 3/24/2014  More...
H. Lundbeck A/S (LUN.CO) And Otsuka Pharmaceutical Co., Ltd. Initiate European Launch Of Abilify Maintena® (Aripiprazole), A Once-Monthly Formulation For The Treatment Of Schizophrenia 3/17/2014  More...
NicOx SA (COX.PA) Launches Adenoplus® And Xailin™ Dry Eye Product Range In Europe 3/17/2014  More...
Alexza Pharmaceuticals, Inc. (ALXA) And Ferrer Internacional Announce The Launch Of ADASUVE® (Inhalation Powder, Loxapine) In Romania 3/14/2014  More...
Sucampo Pharmaceuticals, Inc. (SCMP) Receives Notice That Second Indication For AMITIZA For Opioid-Induced Constipation Is Not Approved By Medicines And Healthcare Products Regulatory Agency In U.K. 3/13/2014  More...
Roche (RHHBY) And Jiangsu Province Bring Down High Cost Of Breast Cancer Drug 3/13/2014  More...
French Competition Regulator Probes Roche (RHHBY), Novartis AG (NVS) 3/12/2014  More...
Novartis AG (NVS) Muscle Drug Sales May Reach $4 Billion, According To MorphoSys AG 3/7/2014  More...
British Watchdog Wants U.S. Biotech Alexion Pharmaceuticals Inc. (ALXN) To Justify Cost Of Drug 3/5/2014  More...
Teva Pharmaceutical Industries Limited (TEVA) Launches ADASUVE® In U.S. 3/3/2014  More...
Bayer AG (BAYN.DE) Eyes At Least 7.5 Billion Euros In Sales From Five Key Drugs 2/28/2014  More...
Essex Medipharma To Distribute Pfizer Inc. (PFE) Glaucoma Eye Drops In China 2/25/2014  More...
Double-Crane Pharmaceutical Co., Ltd. To Distribute Sagent Pharmaceuticals, Inc. Pediatric Drug In China 2/14/2014  More...
Jazz Pharmaceuticals plc (JAZZ) Announces U.S. Commercial Availability Of Versacloz™ (clozapine, USP) Oral Suspension 2/12/2014  More...
Mylan Inc. (MYL) Launches First Trastuzumab Biosimilar, Hertraz™, In India 2/3/2014  More...
Alexza Pharmaceuticals, Inc. (ALXA) Announces Grupo Ferrer Internacional S.A.'s Launch Of ADASUVE® (Staccato® Loxapine) In Spain Triggering A $1 Million Milestone Payment 1/23/2014  More...
Eisai Company, Ltd. (ESALY.PK) Announces Launch Of New "Crystal Veil Mask Bokin 24 Mint" Face Mask Spray Containing Long-Acting Antimicrobial Agent Etak 1/22/2014  More...
H. Lundbeck A/S (LUN.CO)'s Brintellix® (Vortioxetine) For The Treatment Of Major Depressive Disorder In Adults Is Now Available In U.S. Pharmacies 1/21/2014  More...
BioCon Limited (BIOCON.NS) Hits Roche (RHHBY) First, Set To Launch Biosimilar Of Breast Cancer Drug Herceptin 1/21/2014  More...
Vectura Group plc (VEC.L)'s AirFluSal® Forspiro® Launched In Denmark 1/20/2014  More...
Roche (RHHBY) Resolves U.S. Shortage Of Tamiflu For Children 1/17/2014  More...
Seattle Genetics, Inc. (SGEN) Announces ADCETRIS® (Brentuximab Vedotin) Approval In Japan For The Treatment Of Relapsed Or Refractory Hodgkin Lymphoma And Anaplastic Large Cell Lymphoma 1/17/2014  More...
Biogen Idec, Inc. (Massachusetts) (BIIB) Announces Availability Of FAMPYRA® In Ireland To Treat Walking Impairment In Adults With Multiple Sclerosis 1/15/2014  More...
pSivida Corp (PSDV) Reports First Orders For ILUVIEN® Shipped For U.K. National Health Service Hospitals Less Than Seven Weeks After Final National Institute for Clinical Excellence (NICE) Guidance 1/13/2014  More...
UK Lawmakers Criticizes The Government For Spending $702 Million On Roche (RHHBY)'s Tamiflu When Some Researchers Doubt The Medicine's True Efficacy 1/6/2014  More...
Eisai Company, Ltd. (ESALY.PK) Announces Launch of Antiepileptic Drug Fycompa In U.S. 1/6/2014  More...
China Halts Imports Of Pfizer Inc. (PFE)'s Diflucan On Paperwork Glitch 12/31/2013  More...
PhotoCure Release: Regulatory Update On Cevira 12/27/2013  More...
Ipsen (IPN.PA) Prepares For The Resupply Of Increlex® In Europe 12/18/2013  More...
MediGene AG (MDGEF.PK)'s Drug Veregen® Launched In Norway And Sweden 12/18/2013  More...
Health Canada Issues Notice Of Compliance For Gilead Sciences, Inc. (GILD)'s Sovaldi™ (Sofosbuvir) For The Treatment Of Chronic Hepatitis C 12/16/2013  More...
AstraZeneca PLC (AZN) And Bristol-Myers Squibb Company (BMY) Pull Diabetes Drug From Germany 12/16/2013  More...
Notices Sent To Ranbaxy Laboratories (RANBAXY.BO), Cipla Ltd. For Overcharging 12/10/2013  More...
Medivir AB (MVRBF)'s Simeprevir Is Now Available For Hepatitis C Patients In Japan, USA And Canada 12/10/2013  More...
EU Agency Starts In-Depth Review Of Ariad Pharmaceuticals, Inc. (ARIA) Leukemia Drug 12/6/2013  More...
Pfizer Inc. (PFE), Hanmi Pharmaceutical, Co., Ltd Brawl Over Design Of Viagra Pill 12/5/2013  More...
Teva Pharmaceutical Industries Limited (TEVA) Announces Additional Regulatory Exclusivity For TREANDA® (Bendamustine HCI) For Injection 11/27/2013  More...
FDA Lifts Constraints On GlaxoSmithKline (GSK) Diabetes Drug Avandia 11/26/2013  More...
Sosei Group Corporation: Once-Daily Ultibro® Inhalation Capsules (QVA149) For COPD Launched In Japan 11/20/2013  More...
Skyepharma PLC (SKYEF)'s Partner Kyorin Launches Flutiform® In Japan 11/19/2013  More...
WuXi PharmaTech Co., Ltd. To Produce New Cancer Drug For Pharmacyclics, Inc. (PCYC) 11/15/2013  More...
NicOx SA (COX.PA) Launches Sjö™ In The U.S. And Partners With The Sjogren's Syndrome Foundation 11/12/2013  More...
Allied Healthcare Group (AHZ:AU) Makes First Sale of Cardiocel ® Into Europe 11/8/2013  More...
National Institute for Clinical Excellence (NICE): Final Draft OK for Lucentis in Rare Eye Condition 10/25/2013  More...
ADImmune Corporation of Taiwan Readies Flu Vaccine for China 10/25/2013  More...
National Institute for Clinical Excellence (NICE) Draft "Yes" for Astellas Pharma Inc. (ALPMY)' Prostate Cancer Drug 10/18/2013  More...
China National Biotech Group's Japanese Encephalitis Vaccine Prequalified by World Health Organization 10/9/2013  More...
Teva Pharmaceutical Industries Limited (TEVA) Sees Obstacles to Copying GlaxoSmithKline (GSK)'s Best-Selling Drug Advair Before 2018 10/9/2013  More...
National Institute for Clinical Excellence (NICE) Backs Roche (RHHBY)'s MabThera in Rare Autoimmune Disease 10/3/2013  More...
Teva Pharmaceutical Industries Limited (TEVA) Announces Launch of Generic Zemplar® in the United States 10/1/2013  More...
Lundbeck Inc. (LUN.CO) Launches Selincro® in Denmark 9/30/2013  More...
BioTie Therapies Corp.: Selincro Enters the Market in Italy 9/26/2013  More...
Sun Pharmaceutical Industries Ltd May Get Windfall Gains on Cancer Drug Doxil 9/26/2013  More...
Teva Pharmaceutical Industries Limited (TEVA) Copy to Boost Billionaire-Backed Drugmaker 9/18/2013  More...
National Institute for Clinical Excellence (NICE) Demands More Data for Sanofi (France) (SAN.PA)'s Oral MS Drug 9/18/2013  More...
Eisai Company, Ltd. (ESALY.PK)'s EMEA Ops to Supply Fycompa in U.S. 9/12/2013  More...
GlaxoSmithKline (GSK) Declines as FDA Clears Path for Advair Rivals, $8 Billion in Revenue Threatened 9/10/2013  More...
Orexo AB Provides Update on Reimbursement and Launch Preparations for Zubsolv® 9/5/2013  More...
Government Seeks Evidence on PBS-Listed Cancer Drug Yervoy 8/26/2013  More...
Dr. Reddy's Laboratories Ltd. (RDY)’s Announces the Launch of Divalproex Sodium Extended - Release Tablets, USP 8/22/2013  More...
Pfizer Inc. (PFE) Lung Cancer Drug Xalkori Faces UK Rejection as Too Costly 8/19/2013  More...
Moberg Pharma AB (Formerly known as Moberg Derma) Launches Kerasal® NeuroCream at Walmart and Major U.S. Drugstores 8/12/2013  More...
Teva Pharmaceutical Industries Limited (TEVA) and Perrigo Company (PRGO) Announce the U.S. Launch of Generic Temozolomide 8/12/2013  More...
Moberg Pharma AB (Formerly known as Moberg Derma) Launches Kerasal® NeuroCream at Walmart and Major U.S. Drugstores 8/12/2013  More...
XstalBio Launches CentuRecon™ to Accelerate the Delivery of Biologic Drugs at High Concentration 8/12/2013  More...
UK Cost Agency Turns Down New Roche (RHHBY) Breast Cancer Drug 8/6/2013  More...
Roche (RHHBY) Cuts Cost of Drug to Prevent Blindness in HIV Patients 8/6/2013  More...
Zealand Pharma Informs That Sanofi (France) (SAN.PA) has Provided an Update on the Commercial Roll-Out of Lyxumia® 8/1/2013  More...
Teva Pharmaceutical Industries Limited (TEVA)'s Morning-After Pill Now Available on Store Shelves 8/1/2013  More...
BTG plc (BTG.L) Release: TheraSphere® Recommended by the National Institutes of Health (NIH) for the Treatment of Primary and Secondary Liver Cancer 7/30/2013  More...
Dr. Reddy's Laboratories Ltd. (RDY)'s Announces the Launch of Donepezil Hydrochloride Tablets, 23 mg 7/29/2013  More...
Teva Pharmaceutical Industries Limited (TEVA) Gets Exclusivity on Plan B Contraceptive 7/24/2013  More...
Errors, Misconduct, and an Alleged Cover-Up Attempt Delayed Pfizer Inc. (PFE), Bristol-Myers Squibb Company (BMY) Medicine 7/15/2013  More...
Dr. Reddy's Laboratories Ltd. (RDY)'s Announces the Launch of Decitabine for Injection 7/12/2013  More...
A Bayer AG (BAY.F) Drug, the European Medicines Agency and Transparency... or the Lack Thereof 7/11/2013  More...
UK Health Watchdog Doesn't Recommend Novartis AG (NVS)'s Afinitor 7/8/2013  More...
Dr. Reddy's Laboratories Ltd. (RDY)'s Announces the Launch of Lamotrigine Extended-Release Tablets 6/26/2013  More...
Eisai Inc. (ESALF.PK) to Pull Epilepsy Drug From Germany 6/26/2013  More...
Actavis (ACT) Launches Generic Viagra® in Europe as Patents Expire 6/24/2013  More...
UK's National Institute for Clinical Excellence (NICE) Rejects Sanofi (France) (SAN.PA) Bowel Cancer Drug 6/21/2013  More...
SkyePharma Inc. (SKYE) Release: flutiform® Launch in Italy Triggers €2 Million Milestone From Marketing Partner Mundipharma AG 6/20/2013  More...
Novo Nordisk A/S (NVO) Drops as New Eli Lilly and Company (LLY) Drug Threatens Victoza 6/18/2013  More...
Takeda Pharmaceutical Co. Ltd. (TKPYY) Type 2 Diabetes Therapies, NESINA (alogliptin) and Fixed-Dose Combinations KAZANO (alogliptin and metformin HCl) and OSENI (alogliptin and pioglitazone), Are Now Available in Pharmacies in the United States 6/17/2013  More...
Obama Administration Reverses Course on Teva Pharmaceutical Industries Limited (TEVA)'s Plan B Pill 6/11/2013  More...
TiGenix Provides ChondroCelect Update 6/10/2013  More...
FDA Weighs Lifting Safety Restrictions on GlaxoSmithKline (GSK)'s Avandia 6/6/2013  More...
Sacre Bleu! European Agency Rebuffs French Regulator Over Bayer AG (BAY.F) Acne Pill 5/30/2013  More...
Eisai Company, Ltd. (ESALY.PK) Announces Launch of Antiepileptic Agent Inovelon® Tablets 100 mg, 200 mg in Japan 5/28/2013  More...
MEDA: Dymista Reimbursed in Sweden 5/23/2013  More...
Immune Response BioPharma Sets Pricing of REMUNE Vaccine in Thailand Between $75 -100 Per Dose 5/20/2013  More...
EMD Millipore Launches OsteoMAX-XF™, a Fully-Defined, Xeno-Free Mesenchymal Stem Cell Osteogenic Differentiation Medium 5/9/2013  More...
Merck & Co., Inc. (MRK), GlaxoSmithKline (GSK) Reduce HPV Vaccine Prices by 95 Pct. in Poorest Regions 5/9/2013  More...
Non Profit to Bayer AG (BAY.F): Withdraw False Vitamin Claims or Else! 5/9/2013  More...
BioTie Therapies Corp.: Selincro Launched in the United Kingdom 5/6/2013  More...
BioTie Therapies Corp.: Selincro Launched in the United Kingdom 5/6/2013  More...
Retractions?! Conflicts?! Novartis AG (NVS) Probes Diovan Research 5/3/2013  More...
Martindale Pharma® Launches Tapclob®, the First Licensed Oral Liquid Suspension of Clobazam 5/1/2013  More...
EMD Millipore Launches OsteoMAX-XF™, a Fully Defined, Xeno-free Mesenchymal Stem Cell Osteogenic Differentiation Medium 4/30/2013  More...
BioTie Therapies Corp.: Selincro Launched in First European Markets 4/22/2013  More...
Cipla Ltd. Launches Shanghai CP Guojian's Biosimilar in India 4/19/2013  More...
GlaxoSmithKline (GSK)'s Contract Manufacturing Delays Cause Shortage of Restless Leg Treatment 4/18/2013  More...
European Medicines Agency Staff Push to Restrict Servier Osteoporosis Drug 4/15/2013  More...
Dr. Reddy's Laboratories Ltd. (RDY)'s Withdraws Muscle Relaxant From the U.S. 4/11/2013  More...
GW Pharmaceuticals' Cannabinoid-Medicine Sativex® Moved to Schedule 4 of UK Drugs Act 4/10/2013  More...
Novartis AG (NVS) Blockbuster Linked to Retracted Papers 4/2/2013  More...
Dr. Reddy's Laboratories Ltd. (RDY)'s Announces the Launch of Zenatane™ (Isotretinoin Capsules USP) 3/29/2013  More...
Pharming Group (PHGUF.PK) Announces European Medicines Agency Approval of New Manufacturing Site for Ruconest® 3/28/2013  More...
National Institute for Clinical Excellence (NICE) Issues Draft "No" for Pfizer Inc. (PFE)'s Xalkori, but Opens Consultation 3/28/2013  More...
FDA Perspective Published in The New England Journal of Medicine Reinforces Safety of Boehringer Ingelheim Corporation's Pradaxa® (dabigatran etexilate) 3/26/2013  More...
BASF Increases Prices for N,N-Dimethylformamide 3/25/2013  More...
FDA Denies Approval for GlaxoSmithKline (GSK) Bird Flu Vaccine 3/25/2013  More...
GW Pharmaceuticals, Almirall May Pull Cannabis Drug in German Price Row 3/20/2013  More...
Sanofi (France) (SAN.PA): U.S. Probes Disclosures to FDA About Patient Response to Plavix 3/11/2013  More...
Novartis AG (NVS), Roche (RHHBY) Accused by Italy of Eye Drug "Cartel" 2/22/2013  More...
R-Tech Ueno: Announcement of Commercial Availability of RESCULA® Eye Drops in the U.S. Market 2/21/2013  More...
Novartis AG (NVS)'s Jakavi Turned Down by National Institute for Clinical Excellence (NICE) for Blood Cancer 2/13/2013  More...
Ipsen (IPN.PA) Release: Eziclen® / Izinova® a New Product for Bowel Cleansing Successfully Completed European Decentralised Registration Procedure 2/7/2013  More...
Luqa Pharmaceuticals Launches Strataderm® in China 2/1/2013  More...
UK's National Institute for Clinical Excellence (NICE) Rejects Genentech (RHHBY)'s Avastin for Ovarian Cancer 2/1/2013  More...
European Commission (EC) Charges Johnson & Johnson (JNJ) and Novartis AG (NVS) With Pay-to-Delay 1/31/2013  More...
GlaxoSmithKline (GSK) Vaccine Linked to 800 Children Narcolepsy Cases in EU 1/28/2013  More...
AGNSS Recommends Alexion Pharmaceuticals Inc. (ALXN)'s Soliris® (eculizumab) for aHUS and Concludes "Eculizumab Would Help Save Lives and Improve the Quality of Life for Children and Adults With Atypical Haemolytic Uraemic Syndrome" 1/24/2013  More...
Bristol-Myers Squibb Company (BMY), Pfizer Inc. (PFE) Drug Wins National Institute for Clinical Excellence (NICE) Nod for Irregular Heartbeats 1/23/2013  More...
Teijin Pharma to Launch Ipsen (IPN.PA)'s Somatuline® Subcutaneous Injection in the Treatment of Acromegaly and Pituitary Gigantism in Japan 1/17/2013  More...
India Takes Another Swipe at Big Pharmas Such as Bristol-Myers Squibb Company (BMY), Roche (RHHBY); Govt. to Make 3 Key CA Drugs Cheaper 1/14/2013  More...
Journal Refuses to Retract GlaxoSmithKline (GSK)'s Controversial Paxil Study 1/10/2013  More...
Forest Laboratories, Inc. (FRX) and Almirall Announce Commercial Availability of Tudorza™ Pressair™ in U.S. Pharmacies 12/11/2012  More...
National Institute for Clinical Excellence (NICE) Says "No" on Pfizer Inc. (PFE) Kidney Cancer Drug 12/7/2012  More...
Tanzania Expands Immunization Program to Include Pfizer Inc. (PFE)'s Prevenar 13 for Prevention of Pneumococcal Disease 12/5/2012  More...
curasan AG (DX:CUR) Now Sells Bone Regeneration Material in Injectable Form 12/5/2012  More...
Sucampo Pharmaceuticals, Inc. and Abbott Laboratories (ABT) Announce Launch of AMITIZA in Japan 11/26/2012  More...
Dr. Reddy's Laboratories Ltd. (RDY)'s Announces the Launch of SILDENAFIL TABLETS 11/19/2012  More...
Bayer AG (BAY.F) Bets $4 Billion on R8D and Sales From 5 Blockbuster Drugs 11/14/2012  More...
Roche (RHHBY) Fails to Address Question of Missing Tamiflu Data 11/14/2012  More...
Sanofi (France) (SAN.PA) Halves Price of Cancer Drug After Rejection From Cancer Center 11/9/2012  More...
National Institute for Clinical Excellence (NICE) Rejects Novartis AG (NVS) Asthma Drug in Change of Tack 11/9/2012  More...
Cipla Ltd. Slashes Cancer Drug Prices by Up to 64 Pct 11/8/2012  More...
AstraZeneca PLC (AZN), PTSD and a Buried Seroquel Study 11/8/2012  More...
British Medical Journal Pushes Roche (RHHBY) for Raw Data on Tamiflu Trials 10/31/2012  More...
Phagenesis Ltd Launches First Treatment for Acute Dysphagia 10/25/2012  More...
NicOx SA (COX.PA) Launches AdenoPlus™ in the United States 10/22/2012  More...
National Institute for Clinical Excellence (NICE) Stroke Guidance Boost for Boehringer Ingelheim Corporation's Actilyse 10/16/2012  More...
Tarsa Therapeutics to Assist Therapicon in Its Challenge to CHMP's Recommendation to Limit Use of Calcitonin 10/12/2012  More...
National Institute for Clinical Excellence (NICE) U-turns on Novartis AG (NVS)'s Lucentis for Diabetic Macular Oedema 10/5/2012  More...
Dr. Reddy's Laboratories Ltd. (RDY) Announces the Launch of Montelukast Sodium Oral Granules 9/27/2012  More...
Ranbaxy Laboratories (RANBAXY.BO) Misses Out on First-Day Launch of Hypertension Drug's Generic Version 9/26/2012  More...
Dueling Tests Pressure Roche (RHHBY) Bet on Herceptin 9/24/2012  More...
Orexo AB Presents an Update on the U.S. Opioid Dependence Market, and the Commercial Opportunities for Zubsolv™ (OX219) 9/21/2012  More...
Dr. Reddy's Laboratories Ltd. (RDY)'s Announces the Launch of Amoxicillin Tablets, Capsules, and Oral Suspension 9/20/2012  More...
SciClone Pharmaceuticals, Inc. (SCLN) Announces China Government-Mandated ZADAXIN® Price Reduction; Anticipates Minimal Impact on Revenue and Margins 9/18/2012  More...
Medivation, Inc. (MDVN) and Astellas Pharma Inc. (YPH.BE) Announce XTANDI® (Enzalutamide) is Now Available for Patients With Metastatic Castration-Resistant Prostate Cancer Previously Treated With Docetaxel 9/13/2012  More...
Dr. Reddy's Laboratories Ltd. (RDY) Announces the Launch of Metoprolol Succinate ER (Extended-Release) Tablets 9/11/2012  More...
Healthcare Watchdog to Reconsider GlaxoSmithKline (GSK) Drug Benlysta Following Drugmaker's Appeal 9/10/2012  More...
Brazil Seizes Fake Schering-Plough Corporation (SGP) Products 9/4/2012  More...
Wockhardt Launches Generic Version of Anti-Depressant Drug Wellbutrin® SR 9/4/2012  More...
Teva Pharmaceutical Industries Limited (TEVA) Steps Up Defence of Key MS Drug 9/4/2012  More...
Glenmark Pharmaceuticals Wins Right to Sell HIV Diarrhea Drug in 140 Countries 8/23/2012  More...
Roche (RHHBY)'s Avastin Strikes Out Again With National Institute for Clinical Excellence (NICE) 8/23/2012  More...
Teva Pharmaceutical Industries Limited (TEVA) Announces Launch of Generic ACTOplus met® in the United States 8/20/2012  More...
Amgen (AMGN)'s Xgeva Gains National Institute for Clinical Excellence (NICE) Recommendation for Bone Metastasis 8/17/2012  More...
Eisai Inc. (ESALF.PK) CEO Sees "Huge" Medical Need for New Diet Drug 8/15/2012  More...
Roche (RHHBY) Requested by National Institute for Clinical Excellence (NICE) to Provide Further Zelboraf Data 8/13/2012  More...
Did Ranbaxy Laboratories (RANBAXY.BO) Abandon Generic Provigil Launch? 8/8/2012  More...
Melbourn Scientific First to Offer FDA Approved Spray Pattern and Plume Geometry Analysis 8/1/2012  More...
Novartis AG (NVS) Resumes Production of Excedrin 7/26/2012  More...
UK Authority Backs Down in Novartis AG (NVS) Eye Drug Dispute 7/26/2012  More...
National Institute for Clinical Excellence (NICE) Recommends Bayer AG (BAY.F)'s Xarelto 7/25/2012  More...
UCB, Inc. (UCBJF.PK) Launches Neupro® in the U.S. to Treat Parkinson's Disease and Restless Legs Syndrome 7/16/2012  More...
Sanofi (France) (SAN.PA)'s Sleep Driving Drug Should Remain on the Shelves Says Australian Therapeutic Goods Administration 7/10/2012  More...
UK Rejects Roche (RHHBY)'s Avastin in Advanced Breast Cancer 7/9/2012  More...
Astellas Pharma Inc. (YPH.BE) and XenoPort, Inc. (XNPT) Announce the Launch of Regnite® Tablets for Restless Legs Syndrome in Japan 7/9/2012  More...
Dr. Reddy's Laboratories Ltd. (RDY)'s Announces the Launch of Ibandronate Sodium Tablets 7/2/2012  More...
InterMune, Inc. (ITMN) Release: Sweden's Dental and Pharmaceutical Benefits Agency (TLV) Authorizes Reimbursement of Esbriet® (pirfenidone) 6/29/2012  More...
Heart Risk Seen With GlaxoSmithKline (GSK)'s Zofran? 6/29/2012  More...
MEDA: Zyclara Receives Positive Opinion from the Committee for Human Medicinal Products in the European Union 6/25/2012  More...
European Medicines Agency Clears Roche (RHHBY) Cancer Drug MabThera 6/21/2012  More...
National Institute for Clinical Excellence (NICE) Rejects Use of Roche (RHHBY)'s Melanoma Drug Zelboraf 6/18/2012  More...
Amgen (AMGN)'s Xgeva Wins U.K. National Institute for Clinical Excellence (NICE) Backing for Some Cancer Patients 6/12/2012  More...
Roche Holding AG (RHHBF.PK)'s Injectable Boniva Med is in Short Supply 6/8/2012  More...
Dr. Reddy's Laboratories Ltd. (RDY)'s Announces the Launch of Ropinirole Hydrochloride XR (Extended-Release) Tablets 6/7/2012  More...
UK's National Institute for Clinical Excellence (NICE) Recommends Johnson & Johnson (JNJ)'s Xarelto for Treating Blood Clots 6/1/2012  More...
Supplies of Maalox Dwindling Across Canada Caused by Novartis AG (NVS) Shutdown 5/31/2012  More...
Cytori Therapeutics, Inc. (CYTX) Obtains Celution(R) Approval in Russia; to Launch Product Line for Plastic Surgery and Select Soft Tissue Therapies 5/30/2012  More...
European Medicines Evaluation Agency Clears Roche (RHHBY) Cancer Drug MabThera 5/29/2012  More...
Teva Pharmaceutical Industries Limited (TEVA) Decides Not to Launch Generic Lipitor 5/29/2012  More...
Ranbaxy Laboratories (RANBAXY.BO) Plans to Relaunch Skin Drug in the US 5/21/2012  More...
Dr. Reddy's Laboratories Ltd. (RDY) Announces the Launch of Over-the-Counter Lansoprazole Delayed-Release Capsules 5/21/2012  More...
Dr. Reddy's Laboratories Ltd. (RDY)'s Announces the Launch of Clopidogrel Tablets, USP 5/18/2012  More...
National Institute for Clinical Excellence (NICE) Reverses Earlier Decision, Backs Johnson & Johnson (JNJ)'s Zytiga 5/16/2012  More...
National Institute for Clinical Excellence (NICE) Backs Allergan Inc. (AGN)''s Botox for Some Migraine Sufferers 5/11/2012  More...
Teijin Pharma's Febuxostat (FEBURIC) Launches in Taiwan - Novel Drug for Treatment of Hyperuricemia With Gout 5/10/2012  More...